Skip to Main Content (Press Enter)
×
Home
Corsi
Insegnamenti
Professioni
Persone
Pubblicazioni
Strutture
Terza Missione
Attività
Competenze
IT
EN
☰
UNI-FIND
|
UNI-FIND
uninsubria.it
IT
EN
×
Home
Corsi
Insegnamenti
Professioni
Persone
Pubblicazioni
Strutture
Terza Missione
Attività
Competenze
☰
Pubblicazioni
LEUKEMIA
Rivista
Codice:
E101085
ISSN:
0887-6924
Dati Generali
Dati Generali
Pubblicazioni (51)
Pulisci
Ordina Pubblicazioni:
ascendente
decrescente
A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis
Articolo
A prospective study of 338 patients with polycythemia vera: the impact of JAK2 (V617F) allele burden and leukocytosis on fibrotic or leukemic disease transformation and vascular complications.
Articolo
A randomized study of pomalidomide vs placebo in persons with myeloproliferative neoplasm-associated myelofibrosis and RBC-transfusion dependence
Articolo
ACUTE MYELOID LEUKEMIA (AML) HAVING EVOLVED FROM ESSENTIAL THROMBOCYTHEMIA (ET): DISTINCTIVE CHROMOSOME ABNORMALITIES IN PATIENTS TREATED WITH PIPOBROMAN OR HYDROXYUREA
Articolo
BUSULFAN, CYCLOPHOSPHAMIDE AND MELPHALAN AS CONDITIONING REGIMEN FOR BONE MARROW TRANSPLANTATION IN CHILDREN WITH MYELODYSPLASTIC SYNDROMES.
Articolo
Bidirectional linkage between the B-cell receptor and NOTCH1 in chronic lymphocytic leukemia and in Richter's syndrome: therapeutic implications
Articolo
Blast phase myeloproliferative neoplasm: Mayo-AGIMM study of 410 patients from two separate cohorts
Articolo
CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons
Articolo
COVID-19 in Philadelphia-negative myeloproliferative disorders: a GIMEMA survey
Articolo
COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study
Articolo
COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus
Articolo
Clinical end points for drug treatment trials in BCR-ABL1-negative classic myeloproliferative neoplasms: consensus statements from European LeukemiaNET (ELN) and Internation Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT)
Articolo
Compassionate use of JAK1/2 inhibitor ruxolitinib for severe COVID-19: a prospective observational study
Articolo
Deletions of the transcription factor Ikaros in myeloproliferative neoplasms
Articolo
Diagnostic and prognostic role of PET/CT in patients with chronic lymphocytic leukemia and progressive disease
Articolo
Driver mutations' effect in secondary myelofibrosis: An international multicenter study based on 781 patients
Articolo
Effector gammadelta T cells and tumor cells as immune targets of zoledronic acid in multiple myeloma
Articolo
Efficacy and safety of a novel dosing strategy for ruxolitinib in the treatment of patients with myelofibrosis and anemia: the REALISE phase 2 study
Articolo
Evidence- and consensus-based recommendations for phlebotomy in polycythemia vera
Articolo
Functional impact of NOTCH1 mutations in chronic lymphocytic leukemia
Articolo
Galectin-1 suppression delineates a new strategy to inhibit myeloma-induced angiogenesis and tumoral growth in vivo
Articolo
How the coronavirus pandemic has affected the clinical management of Philadelphia-negative chronic myeloproliferative neoplasms in Italy—a GIMEMA MPN WP survey
Articolo
How to manage polycythemia vera
Articolo
IGHV unmutated CLL B cells are more prone to spontaneous apoptosis and subject to environmental prosurvival signals than mutated CLL B cells
Articolo
Incidence and risk factors for bleeding in 1104 patients with essential thrombocythemia or prefibrotic myelofibrosis diagnosed according to the 2008 WHO criteria.
Articolo
Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN international working group
Articolo
Involvement of MAF/SPP1 axis in the development of bone marrow fibrosis in PMF patients
Articolo
JAK inhibitor therapy for myelofibrosis: critical assessment of value and limitations.
Articolo
Leukemia risk models in primary myelofibrosis: an International Working Group study.
Articolo
Life expectancy and prognostic factors in the classic BCR/ABL-negative myeloproliferative disorders
Articolo
Long-term follow-up of idiotype vaccination in human myeloma as a maintenance therapy after high-dose chemotherapy
Articolo
Looking for CALR mutations in familial myeloproliferative neoplasms
Articolo
MEIOTIC ORIGIN OF TRISOMY IN NEOPLASM: EVIDENCE IN A CASE OF ERYTROLEUKAEMIA
Articolo
Monosomy 7 in myeloid malignancies: parental origin and monitoring by real-time quantitative PCR
Articolo
Mutations in NOTCH1 PEST-domain orchestrate CCL19-driven homing of Chronic Lymphocytic Leukemia cells by modulating the tumor suppressor gene DUSP22
Articolo
PRV-1 and its correlation with treatments and disease status in 210 patients with polycythemia vera and essential thrombocythemia
Articolo
Philadelphia chromosome-negative classical myeloproliferative neoplasms: Revised management recommendations from European LeukemiaNet
Articolo
Platelet count predicts driver mutations’ co-occurrence in low JAK2 mutated essential thrombocythemia and myelofibrosis
Articolo
Proposed criteria for the diagnosis of post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a consensus statement from the international working group for myelofibrosis research and treatment
Articolo
Response to the conjugate pneumococcal vaccine (PCV13) in patients with chronic lymphocytic leukemia (CLL)
Articolo
Response to “Questions arising on phlebotomy in polycythemia vera: prophylactic measures to reduce thromboembolic events require patient-focused decisions” by Heidel et al
Articolo
Ruxolitinib and survival improvement in patients with myelofibrosis
Articolo
SPONTANEOUS REMISSION FROM RAEB IN A CHILD
Articolo
Spliceosome mutations are common in persons with myeloproliferative neoplasm-associated myelofibrosis with RBC-transfusion-dependence and correlate with response to pomalidomide
Articolo
Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study.
Articolo
Survival risk score for real-life relapsed/refractory chronic lymphocytic leukemia patients receiving ibrutinib. A campus CLL study
Articolo
The 'GGCC' haplotype of JAK2 confers susceptibility to JAK2 exon 12 mutation-positive polycythemia vera.
Articolo
The enzymatic activities of CD38 enhance CLL growth and trafficking: implications for therapeutic targeting
Articolo
The isochromosome i(7)(q10) carrying c.258+2t>c mutation of the SBDS gene does not promote development of myeloid malignancies in patients with Shwachman syndrome.
Articolo
Validation of a biological score to predict response in chronic lymphocytic leukemia patients treated front-line with bendamustine and rituximab
Articolo
Which patients with myelofibrosis should receive ruxolitinib therapy? ELN-SIE evidence-based recommendations
Articolo
No Results Found
«
‹
{pageNumber}
›
»
{startItem} - {endItem} di {itemsNumber}
5 per pagina
10 per pagina
30 per pagina
vedi tutti
